The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies
- PMID: 36369829
- PMCID: PMC9746450
- DOI: 10.1080/21645515.2022.2143698
The employment of vaccinia virus for colorectal cancer treatment: A review of preclinical and clinical studies
Abstract
Colorectal cancer (CRC) is one of the leading malignancies that causes death worldwide. Cancer vaccines and oncolytic immunotherapy bring new hope for patients with advanced CRC. The capability of vaccinia virus (VV) in carrying foreign genes as antigens or immunostimulatory factors has been demonstrated in animal models. VV of Wyeth, Western Reserve, Lister, Tian Tan, and Copenhagen strains have been engineered for the induction of antitumor response in multiple cancers. This paper summarized the preclinical and clinical application and development of VV serving as cancer vaccines and oncolytic vectors in CRC treatment. Additionally, the remaining challenges and future direction are also discussed.
Keywords: Vaccinia virus; cancer vaccine; clinical; colorectal cancer; oncolytic immunotherapy; preclinical.
Conflict of interest statement
The authors have no relevant financial or non-financial interests to disclose.
Figures
Similar articles
-
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolytics.J Immunother Cancer. 2019 Jan 9;7(1):6. doi: 10.1186/s40425-018-0495-7. J Immunother Cancer. 2019. PMID: 30626434 Free PMC article. Review.
-
Oncolytic and immunologic cancer therapy with GM-CSF-armed vaccinia virus of Tian Tan strain Guang9.Cancer Lett. 2016 Mar 28;372(2):251-7. doi: 10.1016/j.canlet.2016.01.025. Epub 2016 Jan 21. Cancer Lett. 2016. PMID: 26803055
-
Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).EBioMedicine. 2021 Feb;64:103240. doi: 10.1016/j.ebiom.2021.103240. Epub 2021 Feb 10. EBioMedicine. 2021. PMID: 33581644 Free PMC article.
-
Recent progress in combination therapy of oncolytic vaccinia virus.Front Immunol. 2024 Mar 13;15:1272351. doi: 10.3389/fimmu.2024.1272351. eCollection 2024. Front Immunol. 2024. PMID: 38558795 Free PMC article. Review.
-
Progress in gene therapy using oncolytic vaccinia virus as vectors.J Cancer Res Clin Oncol. 2018 Dec;144(12):2433-2440. doi: 10.1007/s00432-018-2762-x. Epub 2018 Oct 6. J Cancer Res Clin Oncol. 2018. PMID: 30293118 Review.
Cited by
-
Clinical Advances and Future Directions of Oncolytic Virotherapy for Head and Neck Cancer.Cancers (Basel). 2023 Nov 4;15(21):5291. doi: 10.3390/cancers15215291. Cancers (Basel). 2023. PMID: 37958464 Free PMC article. Review.
References
-
- Vieira AR, Abar L, Chan DSM, Vingeliene S, Polemiti E, Stevens C, Greenwood D, Norat T. Foods and beverages and colorectal cancer risk: a systematic review and meta-analysis of cohort studies, an update of the evidence of the WCRF-AICR continuous update project. Ann Oncol. 2017;28:1788–802. doi:10.1093/annonc/mdx171. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical